Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mina Hibino"'
Autor:
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 3, Pp 316-325 (2024)
Background and Aims: Assessing aggressive biology at early-stage hepatocellular carcinoma (HCC) diagnosis remains challenging. Alpha-fetoprotein (AFP) is the only clinical biomarker of aggressive HCC. In this study, AFP, Lens culinaris agglutinin-rea
Externí odkaz:
https://doaj.org/article/73dde3b192c541318bdd0fe06f2f0ea5
Autor:
Kelley G. Núñez, Dorota Wyczechowska, Mina Hibino, Tyler Sandow, Juan Gimenez, Ali R. Koksal, Yucel Aydin, Srikanta Dash, Ari J. Cohen, Paul T. Thevenot
Publikováno v:
Livers, Vol 3, Iss 4, Pp 727-738 (2023)
Translational strategies to characterize and monitor extracellular vesicles such as exosome (EX) shedding and the clinical impact of this data within hepatocellular carcinoma (HCC) remains unclear. In this study, EX shedding was assessed in early-sta
Externí odkaz:
https://doaj.org/article/fc31f9d376d44bbe847e34ac33c60eef
Autor:
Kelley G. Núñez, Tyler Sandow, Jai Patel, Mina Hibino, Daniel Fort, Ari J. Cohen, Paul Thevenot
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1684
Due to active hepatocellular carcinoma (HCC) surveillance, many patients are diagnosed with early-stage disease and are usually amendable to curative treatments. These patients lack poor prognostic factors associated with Milan Criteria and alpha fet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4849c8fdaef66e37862efbc416ac618
https://pubmed.ncbi.nlm.nih.gov/35406456
https://pubmed.ncbi.nlm.nih.gov/35406456